DNAJB6P7

Across TCGA pan-cancer cohorts, DNAJB6P7 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated DNAJB6P7 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher DNAJB6P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DNAJB6P7 expression acts as an unfavorable survival marker, although some lineages such as ACC and GBM show a favorable association.

UVM, ACC, and PAAD are the cancer types where DNAJB6P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	III,IV	0.506	0.966	.002	36	view →
ACC	OS	Median	IV	0.842	0.244	.001	32	view →
PAAD	DFS	Quartile	II,III,IV	0.278	0.511	.006	26	view →
GBM	DFS	Median	All	0.310	0.169	.002	22	view →
READ	DFS	Median	III,IV	0.527	0.208	.009	18	view →
THYM	OS	Tertile	III,IV	0.615	1.000	.019	9	view →
KIRC	DFS	Median	All	0.519	0.695	.010	8	view →
STAD	OS	Tertile	III,IV	0.696	0.528	.017	5	view →
CHOL	OS	Tertile	All	0.894	0.479	.037	4	view →
BRCA	DFS	Tertile	All	0.634	0.479	.018	4	view →
CESC	OS	Quartile	All	0.426	0.684	.040	4	view →
COAD	OS	Quartile	All	0.916	0.844	.036	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

DNAJB6P7–UVM (OS)

Open the UVM breakdown →